HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Analysts at HC Wainwright issued their Q1 2026 EPS estimates for HIVE Blockchain Technologies in a research note issued on Thursday, November 14th. HC Wainwright analyst M. Colonnese anticipates that the company will post earnings per share of ($0.04) for the quarter. HC Wainwright has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q2 2026 earnings at $0.00 EPS, Q3 2026 earnings at $0.06 EPS and FY2026 earnings at $0.06 EPS.
Several other brokerages also recently weighed in on HIV. Northland Capmk raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies (CVE:HIV – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported C($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C($0.10) by C($0.01). The company had revenue of C$44.11 million during the quarter, compared to analyst estimates of C$43.64 million.
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- Stock Market Upgrades: What Are They?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- What is Put Option Volume?
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
- What Are Dividend Achievers? An Introduction
- Why Meta Should Rally All The Way Into 2025
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
